Current Diabetes Reports

, Volume 13, Issue 1, pp 34–42 | Cite as

Role of Continuous Glucose Monitoring in the Management of Diabetic Pregnancy

  • Niranjala M. Hewapathirana
  • Esther O’Sullivan
  • Helen R. Murphy
Diabetes and Pregnancy (CJ Homko, Section Editor)

Abstract

Self-monitoring of blood glucose (SMBG) with intermittent capillary glucose fingerstick tests is currently the universally accepted method of glucose monitoring in pregnancy. During pregnancy SMBG tests are recommended before and after meals and before bed (typically 7 values/d). Continuous glucose monitoring systems consist of a disposable subcutaneous glucose-sensing device, electrochemically measuring glucose levels in subcutaneous tissues every 10 seconds, providing an average interstitial glucose value every 5 minutes (typically 288 values/d). From a research perspective this provides unprecedented insights into the pathophysiology of glucose metabolism, while from a clinical perspective it can facilitate enhanced patient-professional decision making, patient motivation, and improved glycaemic control. CGM has thus been described as a “roadmap for effective self-management” and as a “stepping stone in the journey towards a cure.” This review will consider the lessons learned and evidence supporting current and potential future use of CGM in the management of diabetes in pregnancy.

Keywords

Type 1 diabetes Type 2 diabetes Pregnancy Continuous glucose monitoring (CGM) Continuous glucose monitoring systems (CGMS) Self-monitoring of blood glucose (SMBG) Pregestational diabetes Gestational diabetes 

Notes

Disclosure

Conflicts of interest: N.M. Hewapathirana: none; E. O’Sullivan: has received grant support from Novo Nordisk (Research Fellowship 2012/13); support for travel to meetings for the study or otherwise from Pfizer, Sanofi Aventis, MSD

Eli Lilly (travel to ECE/ADA/EASD/Diabetes UK meetings 2008–2012); H.R Murphy: has received grant support from NIHR (HRM Personal Fellowship); is on the European Advisory Board for Medtronic; has received payment for development of educational presentations including service on speakers’ bureaus from Novo Nordisk, Medtronic (CGM manufacturer), and Sanofi-Aventis; has received travel/accommodations expenses covered or reimbursed from Novo Nordisk, Medtronic (CGM manufacturer), and Sanofi-Aventis.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Ali S, Dornhorst A. Diabetes in pregnancy: health risks and management. Postgrad Med J. 2011;87(1028):417–27.Google Scholar
  2. 2.
    Ballas J, Moore TR, Ramos GA. Management of diabetes in pregnancy. Curr Diab Rep. 2012;12:33–42.Google Scholar
  3. 3.
    Kaymak O, Iskender CT, Ustunyurt E, Yildiz Y, Doganay M, Danisman N. Retrospective evaluation of perinatal outcome in women with mild gestational hyperglycemia. J Obstet Gynaecol Res. 2011;37:986–91.Google Scholar
  4. 4.
    Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N Engl J Med. 2008;358:1991–2002.PubMedCrossRefGoogle Scholar
  5. 5.
    Fraser RB, Waite SL, Wood KA, Martin KL. Impact of hyperglycemia on early embryo development and embryopathy: in vitro experiments using a mouse model. Hum Reprod. 2007;22:3059–68.PubMedCrossRefGoogle Scholar
  6. 6.
    Bell R, Glinianaia SV, Tennant PW, Bilous RW, Rankin J. Peri–conception hyperglycaemia and nephropathy are associated with risk of congenital anomaly in women with pre-existing diabetes: a population-based cohort study. Diabetologia. 2012;55(4):936–47.Google Scholar
  7. 7.
    Murphy HR, Roland JM, Skinner TC, Simmons D, Gurnell E, Morrish NJ, et al. Effectiveness of a regional pre-pregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control. Diabetes Care. 2010;33:2514–20.PubMedCrossRefGoogle Scholar
  8. 8.
    Hawthorne G. Maternal complications in diabetic pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:77–90.Google Scholar
  9. 9.
    Ringholm L, Pedersen-Bjergaard U, Thorsteinsson B, Damm P, Mathiesen ER. Hypoglycemia during pregnancy in women with type 1 diabetes. Diabet Med. 2012;29:558–66.PubMedCrossRefGoogle Scholar
  10. 10.
    Rosenn BM, Miodovnik M, Holcberg G, Khoury JC, Siddiqi TA. Hypoglycemia: the price of intensive insulin therapy for pregnant women with insulin-dependent diabetes mellitus. Obstet Gynecol. 1995;85:417–22.PubMedCrossRefGoogle Scholar
  11. 11.
    Kalhan SC, D’Angelo LJ, Savin SM, Adam PA. Glucose production in pregnant women at term gestation. Sources of glucose for human fetus. J Clin Invest. 1979;63:388–94.PubMedCrossRefGoogle Scholar
  12. 12.
    Baumann MU, Deborde S, Illsley NP. Placental glucose transfer and fetal growth. Endocrine. 2002;19:13–22.PubMedCrossRefGoogle Scholar
  13. 13.
    Herranz L, Pallardo LF, Hillman N, Martin-Vaquero P, Villarroel A, Fernandez A. Maternal third trimester hyperglycaemic excursions predict large-for-gestational-age infants in type 1 diabetic pregnancy. Diabetes Res Clin Pract. 2007;75:42–6.PubMedCrossRefGoogle Scholar
  14. 14.
    Kerssen A, de Valk HW, Visser GH. Increased second trimester maternal glucose levels are related to extremely large-for-gestational-age infants in women with type 1 diabetes. Diabetes Care. 2007;30:1069–74.PubMedCrossRefGoogle Scholar
  15. 15.
    Combs CA, Gunderson E, Kitzmiller JL, Gavin LA, Main EK. Relationship of fetal macrosomia to maternal postprandial glucose control during pregnancy. Diabetes Care. 1992;15:1251–7.PubMedCrossRefGoogle Scholar
  16. 16.
    Yessoufou A, Moutairou K. Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of “metabolic memory”. Exp Diabetes Res. 2011. doi:10.1155/2011/218598
  17. 17.
    Reece EA, Homko C, Miodovnik M, Langer O. A consensus report of the diabetes in pregnancy study group of North America conference, Little Rock, Arkansas, May 2002. J Matern Fetal Neonatal Med. 2002;12:362–4.PubMedCrossRefGoogle Scholar
  18. 18.
    Klonoff DC. Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005;28:1231–9.PubMedCrossRefGoogle Scholar
  19. 19.
    Garg S, Zisser H, Schwartz S, Bailey T, Kaplan R, Ellis S, et al. Improvement in glycemic excursions with a transcutaneous, real–time continuous glucose sensor: a randomized controlled trial. Diabetes Care. 2006;29:44–50.PubMedCrossRefGoogle Scholar
  20. 20.
    McCall AL. Insulin therapy and hypoglycemia. Endocrinol Metab Clin North Am. 2012;41:57–87.Google Scholar
  21. 21.
    Yardley JE, Kenny GP, Perkins BA, Riddell MC, Malcolm Boulay J, et al. Effects of performing resistance exercise before vs after aerobic exercise on glycemia in type 1 diabetes. Diabetes Care. 2012;35:669–75.Google Scholar
  22. 22.
    Riddell M, Perkins BA. Exercise and glucose metabolism in persons with diabetes mellitus: perspectives on the role for continuous glucose monitoring. J Diabetes Sci Technol. 2009;3:914–23.PubMedGoogle Scholar
  23. 23.
    Langendam M, Luijf YM, Hooft L, Devries JH, Mudde AH, Scholten RJ. Continuous glucose monitoring systems for type 1 diabetes mellitus. Cochrane Database Syst Rev. 2012. doi:10.1002/14651858.CD008101.pub2
  24. 24.
    Szypowska A, Ramotowska A, Dzygalo K, Golicki D. Beneficial effect of real-time continuous glucose monitoring system on glycemic control in type 1 diabetic patients: systematic review and meta-analysis of randomized trials. Eur J Endocrinol. 2012;166:567–74.Google Scholar
  25. 25.
    Thorsell A, Gordon M, Jovanovic L. Continuous glucose monitoring: a stepping stone in the journey towards a cure for diabetes. J Matern Fetal Neonatal Med. 2004;15(1):15–25.PubMedCrossRefGoogle Scholar
  26. 26.
    • Yogev Y, Ben-Haroush A, Chen R, Rosenn B, Hod M, Langer O. Diurnal glycemic profile in obese and normal weight nondiabetic pregnant women. Am J Obstet Gynecol. 2004;191:949–53. This study provides the first insights into CGM glucose profiles in obese pregnancies.PubMedCrossRefGoogle Scholar
  27. 27.
    Buhling KJ, Winkel T, Wolf C, Kurzidim B, Mahmoudi Wohlfarth MK, et al. Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS). J Perinat Med. 2005;33:125–31.PubMedCrossRefGoogle Scholar
  28. 28.
    • Siegmund T, Rad NT, Ritterath C, Siebert G, Henrich W, Buhling KJ. Longitudinal changes in the continuous glucose profile measured by the CGMS in healthy pregnant women and determination of cut-off values. Eur J Obstet Gynecol Reprod Biol. 2008;139:46–52. This study provides longitudinal CGM profiles during pregnancy and at 6 weeks postpartum.PubMedCrossRefGoogle Scholar
  29. 29.
    Mazze R, Yogev Y, Langer O. Measuring glucose exposure and variability using continuous glucose monitoring in normal and abnormal glucose metabolism in pregnancy. J Matern Fetal Neonatal Med. 2012;25:1171–5.PubMedCrossRefGoogle Scholar
  30. 30.
    Hernandez TL, Friedman JE, Van Pelt RE, Barbour LA. Patterns of glycaemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care. 2011;34:1660–8.PubMedCrossRefGoogle Scholar
  31. 31.
    Ryan EA. Comment on: Hernandez et al. Patterns of glycemia in normal pregnancy: should the current therapeutic targets be challenged? Diabetes Care. 2011;34:1660–8. Diabetes Care. 2011;34:e174; author’s reply e175.CrossRefGoogle Scholar
  32. 32.
    •• Harmon KA, Gerard L, Jensen DR, Kealey EH, Hernandez TL, Reece MS, et al. Continuous glucose profiles in obese and normal-weight pregnant women on a controlled diet: metabolic determinants of fetal growth. Diabetes Care. 2011;34:2198–204. This study provided further insights into the CGM profiles of healthy and obese pregnant women with carefully controlled dietary and gestational age conditions.Google Scholar
  33. 33.
    Ng SK, Olog A, Spinks AB, Cameron CM, Searle J, McClure RJ. Risk factors and obstetric complications of large for gestational age births with adjustments for community effects: results from a new cohort study. BMC Public Health. 2010;10:460.Google Scholar
  34. 34.
    Jolly MC, Sebire NJ, Harris JP, Regan L, Robinson S. Risk factors for macrosomia and its clinical consequences: a study of 350,311 pregnancies. Eur J Obstet Gynecol Reprod Biol. 2003;111:9–14.PubMedCrossRefGoogle Scholar
  35. 35.
    Ben-Haroush A, Yogev Y, Chen R, Rosenn B, Hod M, Langer O. The postprandial glucose profile in the diabetic pregnancy. Am J Obstet Gynecol. 2004;191:576–81.PubMedCrossRefGoogle Scholar
  36. 36.
    Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, et al. Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy. Diabetologia. 2012;55:282–93.Google Scholar
  37. 37.
    Chen R, Yogev Y, Ben-Haroush A, Jovanovic L, Hod M, Phillip M. Continuous glucose monitoring for the evaluation and improved control of gestational diabetes mellitus. J Matern Fetal Neonatal Med. 2003;14:256–60.PubMedCrossRefGoogle Scholar
  38. 38.
    Buhling KJ, Kurzidim B, Wolf C, Wohlfarth K, Mahmoudi M, Wascher C, et al. Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic minimed) in detecting hyperglycaemia by comparing the self-monitoring of blood glucose (SMBG) in non-pregnant women and in pregnant women with impaired glucose tolerance and gestational diabetes. Exp Clin Endocrinol Diabetes. 2004;112:556–60.PubMedCrossRefGoogle Scholar
  39. 39.
    Cypryk K, Pertynska-Marczewska M, Szymczak W, Wilcynski J, Lewinski A. Evaluation of metabolic control in women with gestational diabetes mellitus by the continuous glucose monitoring system: a pilot study. Endocr Pract. 2006;12:245–50.PubMedGoogle Scholar
  40. 40.
    Kestila KK, Ekblad UU, Ronnemaa T. Continuous glucose monitoring vs self-monitoring of blood glucose in the treatment of gestational diabetes mellitus. Diabetes Res Clin Pract. 2007;77:174–9.PubMedCrossRefGoogle Scholar
  41. 41.
    Yogev Y, Chen R, Ben-Haroush A, Phillip M, Jovanovic L, Hod M. Continuous glucose monitoring for the evaluation of gravid women with type 1 diabetes mellitus. Obstet Gynecol. 2003;101:633–8.PubMedCrossRefGoogle Scholar
  42. 42.
    Metzger BE, Gabbe SG, Persson B, Buchanan TA, Catalano PA, Damm P, et al. International association of diabetes and pregnancy study group’s recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care. 2010;33(3):676–82.Google Scholar
  43. 43.
    Schneider S, Bock C, Wetzel M, Maul H, Loerbroks A. The prevalence of gestational diabetes in advanced economies. J Perinat Med. 2012;0(0):1–10.Google Scholar
  44. 44.
    Radder JK, van Roosmalen J. HbA1c in healthy, pregnant women. Neth J Med. 2005;63:256–9.PubMedGoogle Scholar
  45. 45.
    Kerssen A, de Valk HW, Visser GH. Day-to-day glucose variability during pregnancy in women with type 1 diabetes mellitus: glucose profiles measured with the continuous glucose monitoring system. BJOG. 2004;111:919–24.PubMedCrossRefGoogle Scholar
  46. 46.
    Kerssen A, de Valk HW, Visser GH. Do HbA(1)c levels and the self-monitoring of blood glucose levels adequately reflect glycaemic control during pregnancy in women with type 1 diabetes mellitus? Diabetologia. 2006;49:25–8.PubMedCrossRefGoogle Scholar
  47. 47.
    Kerssen A, de Valk HW, Visser GH. Forty-eight-hour first-trimester glucose profiles in women with type 1 diabetes mellitus: a report of three cases of congenital malformation. Prenat Diagn. 2006;26:123–7.PubMedCrossRefGoogle Scholar
  48. 48.
    Kovatchev BP, Cox DJ, Gonder-Frederick LA, Young-Hyman D, Schlundt D, Clarke W. Assessment of risk for severe hypoglycemia among adults with IDDM: validation of the low blood glucose index. Diabetes Care. 1998;21:1870–5.PubMedCrossRefGoogle Scholar
  49. 49.
    Porter H, Lookinland S, Belfort MA. Evaluation of a new real-time blood continuous glucose monitoring system in pregnant women without gestational diabetes. A pilot study. J Perinat Neonatal Nurs. 2004;18:93–102.PubMedGoogle Scholar
  50. 50.
    Dalfra MG, Sartore G, Di Cianni G, Mello G, Lencioni C, Ottanelli S, et al. Glucose variability in diabetic pregnancy. Diabetes Technol Ther. 2011;13:853–9.Google Scholar
  51. 51.
    Zisser HC, Biersmith MA, Jovanovic LB, Yogev Y, Hod M, Kovatchev BP. Fetal risk assessment in pregnancies complicated by diabetes mellitus. J Diabetes Sci Technol. 2010;4(6):1368–73.Google Scholar
  52. 52.
    • Murphy HR, Rayman G, Duffield K, Lewis KS, Kelly S, Johal B, et al. Changes in the glycemic profiles of women with type 1 and type 2 diabetes during pregnancy. Diabetes Care. 2007;30:2785–91. These are the first detailed CGM insights into type 1 and type 2 diabetes pregnancy.PubMedCrossRefGoogle Scholar
  53. 53.
    Stenninger E, Lindqvist A, Aman J, Ostlund I, Schvarcz E. Continuous subcutaneous glucose monitoring system in diabetic mothers during labor and postnatal glucose adaptation of their infants. Diabet Med. 2008;25:450–4.PubMedCrossRefGoogle Scholar
  54. 54.
    •• Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomized clinical trial. BMJ. 2008;337:a1680. This is the only randomized intervention study of CGM in pregestational diabetes.PubMedCrossRefGoogle Scholar
  55. 55.
    Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008;359:1464–76.PubMedCrossRefGoogle Scholar
  56. 56.
    Anderson J, Attvall S, Sternemalm L, Pivodic A, Fahlen M, Hanas R, et al. Effect on glycemic control by short- and long-term use of continuous glucose monitoring in clinical practice. J Diabetes Sci Technol. 2011;5(6):1472–9.Google Scholar
  57. 57.
    Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012;35:32–8.Google Scholar
  58. 58.
    Pickup JC, Freeman SC, Sutton AJ. Glycaemic control in type 1 diabetes during real time continuous glucose monitoring compared with self monitoring of blood glucose: meta-analysis of randomized controlled trials using individual patient data. BMJ. 2011;343:d3805.PubMedCrossRefGoogle Scholar
  59. 59.
    Holmes VA, Young IS, Patterson CC, Pearson DW, Walker JD, Maresh MJ, et al. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial. Diabetes Care. 2011;34:1683–8.PubMedCrossRefGoogle Scholar
  60. 60.
    McLachlan K, Jenkins A, O’Neal D. The role of continuous glucose monitoring in clinical decision-making in diabetes in pregnancy. Aust N Z J Obstet Gynaecol. 2007;47:186–90.PubMedCrossRefGoogle Scholar
  61. 61.
    Secher AL, Madsen AB, Ringholm L, Barfred C, Stage E, Andersen HU, et al. Patient satisfaction and barriers to initiating real-time continuous glucose monitoring in early pregnancy in women with diabetes. Diabet Med. 2012;29:272–7.Google Scholar
  62. 62.
    Murphy HR, Kumareswaran K, Elleri D, Allen JM, Caldwell K, Biagioni M, et al. Safety and efficacy of 24-hour closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care. 2011;34:2527–9.PubMedCrossRefGoogle Scholar
  63. 63.
    Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, et al. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care. 2011;34:406–11.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Niranjala M. Hewapathirana
    • 1
  • Esther O’Sullivan
    • 2
  • Helen R. Murphy
    • 2
    • 3
  1. 1.MRCP, Queens Medical CentreNottingham University Hospitals NHS TrustNottinghamUK
  2. 2.University of Cambridge Metabolic Research Laboratories and NIHR Cambridge Biomedical Research CentreAddenbrooke’s HospitalCambridgeUK
  3. 3.Level 4 Metabolic Research LaboratoriesInstitute of Metabolic ScienceCambridgeUK

Personalised recommendations